“Genetic Polymorphism in CYP3A4 and CYP3A5 Genes and their Association with the Clinical Response to Calcineurin Inhibitors; A Narrative Review” (2024) Precision Medicine Communications, 4(01), pp. 21–40. doi:10.55627/pmc.004.001.0554.